Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 587

Results For "CE"

8160 News Found

Granules partners with Greenko ZeroC to enable green molecule solutions
Sustainability | January 03, 2023

Granules partners with Greenko ZeroC to enable green molecule solutions

Greenko ZeroC will supply Carbon Free Energy and enable Green Hydrogen along with its various chemical derivatives.


MoU signed for commercial production of indigenously developed vaccine ‘Lumpi-ProVac’
Policy | January 02, 2023

MoU signed for commercial production of indigenously developed vaccine ‘Lumpi-ProVac’

Lumpi-ProVacind is used for the prophylactic immunization of animals against Lumpy Skin Disease, which illicit protection for about one year


Survival Technologies files DRHP with SEBI for Rs 1,000 crore IPO
News | January 02, 2023

Survival Technologies files DRHP with SEBI for Rs 1,000 crore IPO

The company is one of the most profitable companies manufacturing speciality chemicals in India


Aster DM Healthcare inks O&M agreement to operate hospital in Mandya
Healthcare | January 01, 2023

Aster DM Healthcare inks O&M agreement to operate hospital in Mandya

The term of O&M is for 15 years with a lock in period of 5 years for the Company and 15 years for VHPL & Bharathi Education trust.


USFDA grants appeal for Ardelyx's XPHOZAH
Drug Approval | December 31, 2022

USFDA grants appeal for Ardelyx's XPHOZAH

Upon approval, XPHOZAH would be the first and only phosphate absorption inhibitor, offering patients a novel mechanism


Samples taken from Marion Biotech Noida facility sent to RDTL, Chandigarh for testing
News | December 30, 2022

Samples taken from Marion Biotech Noida facility sent to RDTL, Chandigarh for testing

There have been reports from Uzbekistan concerning contaminated cough syrup Dok1 Max made by Indian company Marion Biotech, Noida, Uttar Pradesh


Cipla EU to invest € 15 million in Ethris
News | December 30, 2022

Cipla EU to invest € 15 million in Ethris

Cipla and Ethris partner for the development of mRNA-based therapies


Claim against Dr. Reddy’s Laboratories dismissed over Revlimid in US
News | December 30, 2022

Claim against Dr. Reddy’s Laboratories dismissed over Revlimid in US

All claims against the company in the litigation have now been dismissed.


Eye-Q inaugurates its new facility in Yamunanagar
Healthcare | December 30, 2022

Eye-Q inaugurates its new facility in Yamunanagar

The new facility will be able to handle four times as many patients as the previous facility.


Hester to develop low pathogenic avian influenza inactivated vaccine for poultry
News | December 29, 2022

Hester to develop low pathogenic avian influenza inactivated vaccine for poultry

The company has plans to launch this Vaccine by the end of 2023 after completing the required field studies and obtaining regulatory approvals